The ASEPTiCell: The Full Power of Robotics in One Flexible Production System
The ASEPTiCell is where the full power of AST’s automated and robotic solutions meet precision modular engineering for the commercial production of medium-batch liquid pharmaceuticals. Fully automated from start to finish, this highly intuitive, flexible fill-finish system was the industry’s first aseptic multi-format processing machine capable of processing ready-to-use nested vials, cartridges, and syringes on the same line.
American-Made, Worldwide Benefit: Raising the Bar in Isolated Fill-Finish Manufacturing
When AST produced its first fill-finish solution in 2006, two key convictions drove that early innovation: A commitment to imagining a never-before-seen aseptic multi-format processing
From Startup to Standout: Aseptic Processing Solutions for Life Science Innovators
The path to a successful life science startup is exciting, difficult, and unpredictable. Recent years have seen a volatile pattern emerge of challenge, change and
The Future of CDMOs: Aseptic Solutions for Growth and Innovation
When deciding on an aseptic fill/finish machine, the choice to use a gloved or gloveless isolator will arise – and we want to help with that decision. There are a few attributes to consider when choosing between a gloved or a gloveless isolator.
Delivering Flexibility Without Complexity
The pharmaceutical and biotechnology products currently under development or being commercialized are specific and personalized in nature. Given this targeted nature the value of these
Tacoma PharmaSolutions Private Limited
AST announces Indian subsidiary, Tacoma PharmaSolutions Private Limited – a wholly owned Indian subsidiary to keep pace with the regions growing bio-similar and biologics manufacturing